Prague.bio was founded in 2023 with the vision of uniting key players in the life sciences sector in the Czech Republic. Our goal is to integrate R&D, innovation, business, and policy-making activities in Prague and across the country. We strive to create a unified voice for the biotech sector in the Czech Republic.
Founded in 2018 as a scientific spin-off from IOCB Prague, DIANA Biotechnologies has raised €3.5 million in private investment and became the largest producer of COVID-19 tests in Czechia, delivering over 6 million PCR tests to date. The name DIANA stands for DNA-linked Inhibitor Antibody Assay — a method that can precisely detect a variety of diseases.
It targets pathogens and significantly amplifies the evidence of their presence in biological samples. Today, DIANA Biotechnologies provides a wide range of PCR products to diagnostic and academic labs, including custom oligonucleotide synthesis. Their technology also enables the efficient and sensitive development of monoclonal antibodies, and they offer drug discovery services featuring their proprietary DIANA Kinase panels. The company has earned major recognition, including awards like Deloitte Fast 50 and EY Entrepreneur of the Year
